Ana López de la Guía

Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial

María‐Victoria Mateos, Albert Oriol, Joaquín Martínez‐López et al. · Blood · 2012 · 144 citations · Full text

Medicine, Hematology, Oncology +15

GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators?

María‐Victoria Mateos, Albert Oriol, Joaquín Martínez‐López et al. · Blood · 2014 · 102 citations · Full text

Medicine, Hematology, Oncology +14

Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality

Joaquín Martínez‐López, María‐Victoria Mateos, Cristina Encinas et al. · Blood Cancer Journal · 2020 · 78 citations · Full text

Medicine, Hematology, Oncology +12

Smoldering Multiple Myeloma (SMM) at High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) as Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment

María‐Victoria Mateos, Lucía López‐Corral, Miguel‐Teodoro Hernández et al. · Blood · 2010 · 28 citations

Medicine, Hematology, Oncology +15

A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma

Cristina Encinas, José‐Ángel Hernández‐Rivas, Albert Oriol et al. · Blood Cancer Journal · 2022 · 27 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14